Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Insider Profile

SHERMAN JEFFREY W

Director | SEC CIK: 0001230482

Comprehensive Trading Performance Summary

The investment footprint of SHERMAN JEFFREY W as disclosed via official SEC Form 4 filings provides a critical window into professional capital allocation strategies. By tracking this specific portfolio, investors can analyze how this individual moves capital across different boards and sectors. High-conviction moves by key stakeholders often serve as leading indicators for future market performance, as they reflect the intimate operational knowledge and fiduciary confidence of those closest to the company's decision-making process. Monitoring these strategic accumulation or exit patterns helps bridge the gap between institutional boardrooms and the retail investment community.

Filing Date Trade Date Ticker Company Name Industry Relationship Type Price Qty Total, $ Owned After Change, %
2026-03-03 00:30 2026-02-27 LRMR Larimar Therapeutics, Inc. Pharmaceutical Preparations Director BUY $5.00 5,000 $25,000 5,000 +100.0%
2025-08-30 00:21 2025-08-28 XERS Xeris Biopharma Holdings, Inc. Pharmaceutical Preparations Director OPT+S $7.92 42,232 $334,515 219,188 0.0%
2023-11-30 00:09 2023-11-27 XERS Xeris Biopharma Holdings, Inc. Pharmaceutical Preparations Director BUY $1.87 5,400 $10,098 5,400 +100.0%
2023-01-13 00:29 2023-01-10 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $113.08 6,736 $761,673 36,171 -15.7%
2023-01-07 01:54 2023-01-06 HZNP N/A Other Officer - EVP and Chief Medical Officer OPT+S $113.29 5,187 $587,635 49,314 0.0%
2022-12-14 00:12 2022-12-12 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $111.45 28,352 $3,159,691 84,430 -25.1%
2022-04-08 23:07 2022-04-06 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $110.02 42,009 $4,621,872 10,629 -79.8%
2021-09-24 00:00 2021-09-21 HZNP N/A Other Officer - EVP and Chief Medical Officer OPT+S $110.00 46,271 $5,089,810 9,115 0.0%
2021-07-03 00:02 2021-07-01 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $95.00 60,076 $5,707,364 128,845 -31.8%
2020-12-10 01:05 2020-12-07 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $71.02 103,842 $7,375,212 174,955 -37.2%
2020-07-08 01:49 2020-07-06 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $57.50 9,100 $523,250 278,797 -3.2%
2020-05-12 23:12 2020-05-11 HZNP N/A Other Officer - EVP and Chief Medical Officer OPT+S $45.00 33,479 $1,506,555 13,966 0.0%
2016-08-02 23:44 2016-08-02 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $20.00 2,900 $58,000 159,250 -1.8%
2016-03-01 03:10 2016-02-26 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $20.00 4,100 $82,000 149,648 -2.7%
2015-12-11 00:55 2015-12-10 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $20.00 4,456 $89,120 105,132 -4.1%
2015-09-22 01:59 2015-09-21 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $31.78 7,750 $246,295 105,132 -6.9%
2015-07-17 23:36 2015-07-15 HZNP N/A Other Officer - EVP and Chief Medical Officer OPT+S $35.55 26,887 $955,833 112,882 0.0%
2014-11-21 02:18 2014-11-19 HZNP N/A Other Officer - EVP and Chief Medical Officer SELL $12.05 24,999 $301,238 74,299 -25.2%
2013-01-03 22:36 2013-01-02 HZNP N/A Other Officer - EVP & Chief Medical Officer SELL $2.36 16,304 $38,477 55,099 -22.8%
2006-09-29 01:10 2006-09-27 NEOL N/A Other Officer - Ex. VP - Chief Medical Officer BUY $4.98 1,000 $4,980 3,281 +43.8%
2004-05-19 21:10 2004-05-17 NEOL N/A Other Officer - EX. VP BUY $14.06 100 $1,406 214,186 +0.0%
SHOW ENTRIES

Tracking Multi-Role Insiders: SHERMAN JEFFREY W

High-level stakeholders like SHERMAN JEFFREY W, whether acting as directors, officers, or 10% owners, often possess unique cross-sector insights. Monitoring a specific CIK like 0001230482 allows investors to identify recurring patterns of trading success across various industries. When a large 10% shareholder or a key beneficial owner moves capital, it often signals a strategic shift in institutional or private conviction.

SEC Transparency for Key Stakeholders

Every market move made by SHERMAN JEFFREY W is a matter of public record under federal law. By aggregating Form 4 filings, we provide transparency into the portfolios of major players who hold significant influence. Following the money of those with a 10% stake or executive power helps bridge the information gap between the boardroom and the retail investor.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.